ReviewExpert review of gastroenterology & hepatology2012

Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer.

Nathaniel S Rial et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.